BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37775407)

  • 1. Intervention effect of electroacupuncture therapy on drug reducing and discontinuation of insomnia patients with long-term excessive use of zolpidem.
    Zhang H; Rong H; Xiong S; Chen X; Lin Z
    Explore (NY); 2024; 20(3):328-333. PubMed ID: 37775407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
    Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
    JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxepin is more effective than zolpidem in improving executive function in patients with insomnia disorder.
    Yu Z; Han L; Yan P; Liu W; Ren L; Xu Y; Yang L; Ma L; Liu Y; Wang S
    Sleep Breath; 2024 May; 28(2):929-934. PubMed ID: 38123719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): A Randomized Clinical Trial.
    McCall WV; Benca RM; Rosenquist PB; Youssef NA; McCloud L; Newman JC; Case D; Rumble ME; Szabo ST; Phillips M; Krystal AD
    Am J Psychiatry; 2019 Nov; 176(11):957-965. PubMed ID: 31537089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zolpidem for persistent insomnia in SSRI-treated depressed patients.
    Asnis GM; Chakraburtty A; DuBoff EA; Krystal A; Londborg PD; Rosenberg R; Roth-Schechter B; Scharf MB; Walsh JK
    J Clin Psychiatry; 1999 Oct; 60(10):668-76. PubMed ID: 10549683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial.
    Maroo N; Hazra A; Das T
    Indian J Pharmacol; 2013; 45(1):34-9. PubMed ID: 23543804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R; Rüther E; Farr I; Emilien G; Salinas E
    J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sedative-hypnotics on sleep quality among patients with insomnia: evidence from an observational, pre-post study in India.
    Satheesh G; Puthean S; Sharma A; Mishra SR; Jose J; Kakkan S; Unnikrishnan MK
    Health Qual Life Outcomes; 2020 Jul; 18(1):212. PubMed ID: 32631438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial.
    Morin CM; Vallières A; Guay B; Ivers H; Savard J; Mérette C; Bastien C; Baillargeon L
    JAMA; 2009 May; 301(19):2005-15. PubMed ID: 19454639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T; Soubrane C; Titeux L; Walsh JK;
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of zolpidem on sleep parameters in patients with cirrhosis and sleep disturbances: A randomized, placebo-controlled trial.
    Sharma MK; Kainth S; Kumar S; Bhardwaj A; Agarwal HK; Maiwall R; Jamwal KD; Shasthry SM; Jindal A; Choudhary A; Anand L; Dhamija RM; Kumar G; Sharma BC; Sarin SK
    Clin Mol Hepatol; 2019 Jun; 25(2):199-209. PubMed ID: 30856689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Sequential Psychological and Medication Therapies for Insomnia Disorder: A Randomized Clinical Trial.
    Morin CM; Edinger JD; Beaulieu-Bonneau S; Ivers H; Krystal AD; Guay B; Bélanger L; Cartwright A; Simmons B; Lamy M; Busby M
    JAMA Psychiatry; 2020 Nov; 77(11):1107-1115. PubMed ID: 32639561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Maintenance of Therapeutic Gains Associated With Cognitive-Behavioral Therapy for Insomnia Delivered Alone or Combined With Zolpidem.
    Beaulieu-Bonneau S; Ivers H; Guay B; Morin CM
    Sleep; 2017 Mar; 40(3):. PubMed ID: 28364426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep in patients with chronic primary insomnia during long-term zolpidem administration and after its withdrawal.
    Monti JM; Monti D; Estévez F; Giusti M
    Int Clin Psychopharmacol; 1996 Dec; 11(4):255-63. PubMed ID: 9031992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia.
    Perlis ML; McCall WV; Krystal AD; Walsh JK
    J Clin Psychiatry; 2004 Aug; 65(8):1128-37. PubMed ID: 15323600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of insomnia related to depressive disorders. Effects of zolpidem versus flunitrazepam administration and withdrawal evaluated in a double-blind study].
    Guazzelli M; Ciapparelli A; Balsamo EL; Gemignani A; Sarteschi P
    Minerva Psichiatr; 1993 Sep; 34(3):193-203. PubMed ID: 8302193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal from long-term use of zopiclone, zolpidem and temazepam may improve perceived sleep and quality of life in older adults with primary insomnia.
    Lähteenmäki R; Neuvonen PJ; Puustinen J; Vahlberg T; Partinen M; Räihä I; Kivelä SL
    Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):330-340. PubMed ID: 30295409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperarousal in insomnia: pre-sleep and diurnal cortisol levels in response to chronic zolpidem treatment.
    Roehrs T; Roth T
    Sleep Med; 2019 Sep; 61():52-56. PubMed ID: 31255482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
    Roth T; Krystal A; Steinberg FJ; Singh NN; Moline M
    Sleep; 2013 Feb; 36(2):189-96. PubMed ID: 23372266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.